Oxidative Stress Clinical Trial
Official title:
The Effects of Antioxidant Supplementation on Multiple Endurance Race Performance, Physiology, and Recovery.
NCT number | NCT04314596 |
Other study ID # | 1219 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 20, 2020 |
Est. completion date | February 19, 2020 |
Verified date | March 2020 |
Source | Applied Science & Performance Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Thirty active male and female athletes will be recruited for the study. Subjects will be examined at baseline for VO2max performance. Subjects will then be stratified and randomly divided equally (50% - 50%) into an Oceanix (supplemental) or placebo condition such that baseline VO2max match. Once randomization, subjects will be baseline tested for multiple measures of muscle force capacity, muscle soreness, immune function, and endocrine function. Upon completion of baseline testing, subjects will all complete a one-day, cross-training course in Tampa, Florida. The training course is known to be extremely vigorous and causes significant muscle damage. Subjects will then be retested for muscle function at 24, and 48 hours following the course. At 24- and 48-hours subjects will be asked to repeat a simulated time trial race. In this way, we will measure repeated race performance, recovery from intense exercise, muscle damage from exercise, and immune function during multiple races.
Status | Completed |
Enrollment | 18 |
Est. completion date | February 19, 2020 |
Est. primary completion date | February 12, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Males and females age 18 to 45 years old - At least one year of cross training experience (i.e. 3 days/week) Exclusion Criteria: - BMI of 30 or more kg/m² - Any allergies to fish, shellfish, algae, or seaweed are excluded from participation - Have any cardiovascular, metabolic, or endocrine disease - Undergone surgery that affects digestion and absorption - Smoking - Drink heavily (> 7 and > 14 drinks per week for women and men, respectively) - Women who are pregnant or planning to be pregnant - Taking medication to control blood pressure, lipids, and blood glucose - Have taken or currently taking anabolic-androgenic steroids |
Country | Name | City | State |
---|---|---|---|
United States | Applied Science & Performance Institute | Tampa | Florida |
Lead Sponsor | Collaborator |
---|---|
Applied Science & Performance Institute | Lonza Ltd. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | VO2max | Assessment of VO2max to determine fitness level and use as basis for randomization. | Baseline | |
Primary | Changes in muscle strength | Assessed by isometric mid-thigh pull. | Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Primary | Changes in muscle power | Assessed through ground reaction forces during countermovement and squat jumps on a force plate. | Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Primary | Changes in One(1) Mile Timed Run | Experimental outcome assessing how quickly a 1 mile run can be completed. | Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Primary | Changes in Perceived Recovery Status (PRS) | Assessed through a visual analog scale (modified Borg Scale) numbered 0 to 10 with visual descriptors. | Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Primary | Changes in Rating of Perceived Exertion (RPE) | Assessed through a visual analog scale numbered 0 to 10 with visual descriptors. | Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Primary | Changes in Perceived Soreness Scale | Assessed through a visual analog scale numbered 0 to 10 with visual descriptors. | Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Secondary | Creatine Kinase | Experimental outcome examining creatine kinase in fasted whole blood samples. This is biomarker an indirect measure of muscle damage. | Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. | |
Secondary | Cortisol | Experimental outcome examining the concentration of cortisol in fasted saliva samples. | Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04136821 -
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
|
N/A | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Completed |
NCT03358524 -
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
|
Phase 4 | |
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT03288623 -
The Effects of Dark Chocolate Implementation in Elite Athletes
|
N/A | |
Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Enrolling by invitation |
NCT03030456 -
Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders
|
N/A | |
Completed |
NCT02256254 -
SIMOX - Induction of Oxidative Stress
|
Phase 2 | |
Not yet recruiting |
NCT02202239 -
Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients
|
Phase 4 | |
Recruiting |
NCT02048592 -
Impact of Immunonutrition on the Patients With Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01942460 -
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT02463318 -
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects
|
N/A | |
Completed |
NCT02177383 -
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
|
N/A | |
Completed |
NCT01990391 -
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities
|
N/A | |
Completed |
NCT00845130 -
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 |